Janssen files suit in U.S. to block sale of Samsung Bioepis’ Remicade copy

May 18, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital

SEOUL (Reuters) – A unit of healthcare conglomerate Johnson & Johnson filed a lawsuit to block a copy of its rheumatoid arthritis drug Remicade made by South Korea’s Samsung Bioepis Co Ltd from being sold in the United States.